NCT02377206View on ClinicalTrials.gov

Neuroinflammation and Cognitive Decline in Alzheimer Disease

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 6, 2016

Primary Completion Date

December 4, 2019

Study Completion Date

December 4, 2019

Conditions
Alzheimer Disease
Interventions
OTHER

ADAS-Cog evaluation

\[18F\]DPA-714 PET imaging

Trial Locations (3)

35000

University Hospital of Rennes, Rennes

37044

University Hospital of Tours, Tours

44000

university hospital of Nantes, Nantes

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT02377206 - Neuroinflammation and Cognitive Decline in Alzheimer Disease | Biotech Hunter | Biotech Hunter